[go: up one dir, main page]

SE0301882D0 - New use I - Google Patents

New use I

Info

Publication number
SE0301882D0
SE0301882D0 SE0301882A SE0301882A SE0301882D0 SE 0301882 D0 SE0301882 D0 SE 0301882D0 SE 0301882 A SE0301882 A SE 0301882A SE 0301882 A SE0301882 A SE 0301882A SE 0301882 D0 SE0301882 D0 SE 0301882D0
Authority
SE
Sweden
Prior art keywords
wound healing
new use
promoting wound
inhibitor
mammal
Prior art date
Application number
SE0301882A
Other languages
Swedish (sv)
Inventor
Cecilia Nilsson
Catrine Nilsson
Original Assignee
Biovitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovitrum Ab filed Critical Biovitrum Ab
Priority to SE0301882A priority Critical patent/SE0301882D0/en
Publication of SE0301882D0 publication Critical patent/SE0301882D0/en
Priority to KR1020057024626A priority patent/KR20060023570A/en
Priority to PCT/SE2004/000996 priority patent/WO2004112784A1/en
Priority to EP04749034A priority patent/EP1638553A1/en
Priority to AU2004249099A priority patent/AU2004249099A1/en
Priority to CA002529406A priority patent/CA2529406A1/en
Priority to JP2006517048A priority patent/JP2007521264A/en
Priority to CNA2004800177434A priority patent/CN1812784A/en
Priority to NO20060416A priority patent/NO20060416L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

The invention relates to a method for promoting wound healing, said method comprising administering to a mammal, including man, in need of such promotion an effective amount of an inhibitor of 11-b-hydroxysteroid dehydrogenase type 1, wherein the said 11b-HSD1 inhibitor has the formula (I) wherein T, B, X, Y, R1 and R2 are as defined in the specification. These compounds may also be used in the manufacture of a medicament for promoting wound healing.
SE0301882A 2003-06-25 2003-06-25 New use I SE0301882D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE0301882A SE0301882D0 (en) 2003-06-25 2003-06-25 New use I
KR1020057024626A KR20060023570A (en) 2003-06-25 2004-06-21 New Use I
PCT/SE2004/000996 WO2004112784A1 (en) 2003-06-25 2004-06-21 New use i
EP04749034A EP1638553A1 (en) 2003-06-25 2004-06-21 New use i
AU2004249099A AU2004249099A1 (en) 2003-06-25 2004-06-21 New use I
CA002529406A CA2529406A1 (en) 2003-06-25 2004-06-21 New use i
JP2006517048A JP2007521264A (en) 2003-06-25 2004-06-21 New Use I
CNA2004800177434A CN1812784A (en) 2003-06-25 2004-06-21 New use i
NO20060416A NO20060416L (en) 2003-06-25 2006-01-25 New use I

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0301882A SE0301882D0 (en) 2003-06-25 2003-06-25 New use I

Publications (1)

Publication Number Publication Date
SE0301882D0 true SE0301882D0 (en) 2003-06-25

Family

ID=27656617

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0301882A SE0301882D0 (en) 2003-06-25 2003-06-25 New use I

Country Status (9)

Country Link
EP (1) EP1638553A1 (en)
JP (1) JP2007521264A (en)
KR (1) KR20060023570A (en)
CN (1) CN1812784A (en)
AU (1) AU2004249099A1 (en)
CA (1) CA2529406A1 (en)
NO (1) NO20060416L (en)
SE (1) SE0301882D0 (en)
WO (1) WO2004112784A1 (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8686011B2 (en) 2004-05-24 2014-04-01 Amgen Inc. Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
CA2568186C (en) 2004-05-24 2011-11-15 Amgen Inc. Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
GB0506133D0 (en) * 2005-03-24 2005-05-04 Sterix Ltd Compound
WO2006105127A2 (en) 2005-03-31 2006-10-05 Takeda San Diego, Inc. Hydroxysteroid dehydrogenase inhibitors
US7622492B2 (en) 2005-08-31 2009-11-24 Hoffmann-La Roche Inc. Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase
AU2006316867A1 (en) 2005-11-22 2007-05-31 Amgen Inc. Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
EP2061767B1 (en) 2006-08-08 2014-12-17 Sanofi Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use
JP5098011B2 (en) * 2006-11-20 2012-12-12 国立大学法人山口大学 Wound healing promoter
DE102007005045B4 (en) 2007-01-26 2008-12-18 Sanofi-Aventis Phenothiazine derivatives, process for their preparation and their use as medicines
JP5463285B2 (en) * 2007-07-13 2014-04-09 アイカジェン， インコーポレイテッド Sodium channel inhibitor
EP2025674A1 (en) 2007-08-15 2009-02-18 sanofi-aventis Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs
US8470841B2 (en) 2008-07-09 2013-06-25 Sanofi Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
CN102482312A (en) 2009-08-26 2012-05-30 赛诺菲 Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
WO2011107494A1 (en) 2010-03-03 2011-09-09 Sanofi Novel aromatic glycoside derivatives, medicaments containing said compounds, and the use thereof
EP2582709B1 (en) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
WO2012120056A1 (en) 2011-03-08 2012-09-13 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
EP2683702B1 (en) 2011-03-08 2014-12-24 Sanofi New substituted phenyl oxathiazine derivatives, method for their manufacture, medicines containing these compounds and their application
EP2683703B1 (en) 2011-03-08 2015-05-27 Sanofi Novel substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
US8901114B2 (en) 2011-03-08 2014-12-02 Sanofi Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
WO2012120051A1 (en) 2011-03-08 2012-09-13 Sanofi Benzyl-oxathiazine derivates substituted with adamantane or noradamantane, medicaments containing said compounds and use thereof
EP2683705B1 (en) 2011-03-08 2015-04-22 Sanofi Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
US8846666B2 (en) 2011-03-08 2014-09-30 Sanofi Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
EP2683699B1 (en) 2011-03-08 2015-06-24 Sanofi Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120053A1 (en) 2011-03-08 2012-09-13 Sanofi Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en) 2011-09-27 2015-10-21 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
CN103204824B (en) * 2012-01-12 2015-04-08 清华大学深圳研究生院 2-aminothiazole-4-amide derivative, its preparation method and application
TW201512171A (en) 2013-04-19 2015-04-01 Pfizer Ltd Chemical compounds
CN105061288B (en) * 2015-08-07 2017-09-15 武汉华素康生物科技有限公司 Compound and its preparation method and application
EP3235813A1 (en) 2016-04-19 2017-10-25 Cidqo 2012, S.L. Aza-tetra-cyclo derivatives
CN118340765B (en) * 2024-04-30 2024-08-23 广州市朝利良生物科技有限公司 Application of benzamide compound in preparation of wound healing promoting medicine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH10639A (en) * 1967-07-17 1977-07-22 Research Corp Method of treatment and composition containing silver sulfadiazine
EP1048657A1 (en) * 1995-04-04 2000-11-02 Texas Biotechnology Corporation Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
DE69718038D1 (en) * 1996-10-16 2003-01-30 American Cyanamid Co PRODUCTION AND USE OF ORTHO-SULFONAMIDO-HETEROARYLHYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS
SE0001899D0 (en) * 2000-05-22 2000-05-22 Pharmacia & Upjohn Ab New compounds

Also Published As

Publication number Publication date
EP1638553A1 (en) 2006-03-29
CA2529406A1 (en) 2004-12-29
NO20060416L (en) 2006-03-24
JP2007521264A (en) 2007-08-02
AU2004249099A1 (en) 2004-12-29
CN1812784A (en) 2006-08-02
WO2004112784A1 (en) 2004-12-29
KR20060023570A (en) 2006-03-14

Similar Documents

Publication Publication Date Title
SE0301882D0 (en) New use I
SE0301886D0 (en) New use V
SE0301888D0 (en) New use VII
MY148690A (en) Novel macrocyclic inhibitors of hepatitis c virus replication
SE0101387D0 (en) Novel compounds
EA201000563A1 (en) TRIAZOLPYRIDINE INHIBITORS 11-BETA-HYDROXYSTEROID - DEHYDROGENASE TYPE I
JO2282B1 (en) Oxazol derivatives
CY1109242T1 (en) THERAPEUTIC AGENTS USEFUL FOR PAIN TREATMENT
ATE373474T1 (en) SUBSTITUTED 2-AMINOTETRALINE FOR THE TREATMENT OF DEPRESSION
IL192103A0 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
NO20083032L (en) Use of benzofused heterocyclic sulfamide derivatives for the treatment of mania and bipolar disorder
CY1109763T1 (en) MATERIALS AND METHOD FOR TREATMENT OF CELLULAR DISORDERS
MXPA05000765A (en) 5-aryltetrazole compounds, compositions thereof, and uses therefor.
PE20030061A1 (en) 1-BIARIL-1,8-NAPHTHYRIDIN-4-ONA AS PHOSPHODIESTERASE-4 INHIBITORS
MY143568A (en) 11b-hsd1 inhibitors for the treatment of diabetes
DE602006010442D1 (en) USE OF BENZO-CONDENSED HETEROCYCLIC SULPHAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN
MXPA05010020A (en) Oxamide derivatives useful as raf-kinase inhibitors.
SE0301883D0 (en) New use II
SE0004101D0 (en) New use
SE0301885D0 (en) New use IV
SE0301884D0 (en) New use III
SE0002739D0 (en) New use
TW200600084A (en) Anti-coronavirus compounds
ATE308513T1 (en) NAPHTHAMIDE NEUROKININ ANTAGONISTS FOR USE AS MEDICATIONS
SE0201939D0 (en) New combination